Lilly's migraine treatment Emgality lands in Korea - Korea Biomedical Review

Submitted by Anonymous (not verified) on Thu, 09/05/2019 - 07:24

Lilly's migraine treatment Emgality lands in Korea  Korea Biomedical ReviewLilly's new migraine treatment Emgality Prefilled Pen Inj. (ingredient: galcanezumab) has won a local license. The Ministry of Food and Drug Safety on Thursday ...